Assignee
ADIMAB LLC
US24 patents
Top patents by PatentIndex Score
US10189894B2Jan 29, 2019
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC6 citations84
US10196635B2Feb 5, 2019
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC4 citations73
US12018403B2Jun 25, 2024
Antibody libraries
ADIMAB LLC1 citations72
US10889811B2Jan 12, 2021
Antibody libraries
ADIMAB LLC1 citations72
US10787500B2Sep 29, 2020
Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
ADIMAB LLC2 citations72
US10138478B2Nov 27, 2018
Antibody libraries
ADIMAB LLC3 citations72
US11479600B2Oct 25, 2022
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
ADIMAB LLC2 citations70
US11312761B2Apr 26, 2022
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
ADIMAB LLC3 citations70
US10883997B2Jan 5, 2021
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC1 citations68
US10156574B2Dec 18, 2018
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC2 citations68
US10329555B2Jun 25, 2019
High throughput generation and affinity maturation of humanized antibody
ADIMAB LLC3 citations67
US11008383B2May 18, 2021
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC1 citations62
US11008568B2May 18, 2021
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC1 citations62
US12258679B2Mar 25, 2025
Polyclonal mixtures of antibodies, and methods of making and using them
ADIMAB LLC0 citations61
US11390964B2Jul 19, 2022
Polyclonal mixtures of antibodies, and methods of making and using them
ADIMAB LLC1 citations61
US10684289B2Jun 16, 2020
Polyclonal mixtures of antibodies, and methods of making and using them
ADIMAB LLC1 citations61
US12281156B2Apr 22, 2025
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
ADIMAB LLC0 citations60
US12215141B2Feb 4, 2025
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
ADIMAB LLC0 citations60
US11485775B2Nov 1, 2022
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
ADIMAB LLC1 citations60
US11542330B2Jan 3, 2023
Anti-CD3-binding domains and antibodies comprising them, and methods for their generation and use
ADIMAB LLC1 citations59
US12552863B2Feb 17, 2026
High affinity anti-CD3 antibodies, and methods for their generation and use
ADIMAB LLC0 citations58
US12181480B2Dec 31, 2024
Polyspecificity reagents, methods for their preparation and use
ADIMAB LLC0 citations57
US12529164B2Jan 20, 2026
Rationally designed, synthetic antibody libraries and uses therefor
ADIMAB LLC0 citations52
US12180299B2Dec 31, 2024
Multispecific antibody analogs comprising a common light chain, and methods of their preparation and use
ADIMAB LLC0 citations50